9 Einträge gefunden

1. The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery

   1. Schmitz, Lisa
   2. Berdien, Belinda
   3. Huland, Edith
   4. Dase, Petra
   5. Beutel, Karin
   6. Fisch, Margit
   7. Engel, Oliver

   2020 - Forschungsinformationssystem des UKE
2. Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSA.

   1. Aalamian-Matheis, Maryam
   2. Chatta, Gurkamal S
   3. Shurin, Michael R
   4. Huland, Edith
   5. Huland, Hartwig
   6. Shurin, Galina V

   2007 - Forschungsinformationssystem des UKE
3. Interleukin-2 inhalation therapy temporarily induces asthma-like airway inflammation.

   1. Loppow, D
   2. Huland, Edith
   3. Heinzer, Hans
   4. Grönke, L
   5. Magnussen, H
   6. Holz, O
   7. Jörres, Rudolf A

   2007 - Forschungsinformationssystem des UKE
4. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

   1. Haese, Alexander
   2. Graefen, Markus
   3. Steuber, Thomas
   4. Becker, Charlotte
   5. Noldus, Joachim
   6. Erbersdobler, Andreas
   7. Huland, Edith

   2003 - Forschungsinformationssystem des UKE
5. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.

   1. Haese, Alexander
   2. Graefen, Markus
   3. Becker, Charlotte
   4. Noldus, Joachin
   5. Katz, Jared
   6. Cagiannos, Ilias
   7. Kattan, Michael

   2003 - Forschungsinformationssystem des UKE
6. Prediction of tumor heterogeneity in localized prostate cancer.

   1. Huland, Hartwig
   2. Graefen, Markus
   3. Haese, Alexander
   4. Hammerer, Peter G
   5. Palisaar, Juri
   6. Pichlmeier, Uwe
   7. Henke, Rolf-P

   2002 - Forschungsinformationssystem des UKE
7. Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.

   1. Friedrich, Martin
   2. Hellstern, Angelika
   3. Hautmann, Stefan H
   4. Graefen, Markus
   5. Conrad, Stefan
   6. Huland, Edith
   7. Huland, Hartwig

   2002 - Forschungsinformationssystem des UKE
8. Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.

   1. Palisaar, R Jüri
   2. Graefen, Markus
   3. Karakiewicz, Pierre I
   4. Hammerer, Peter G
   5. Huland, Edith
   6. Haese, Alexander
   7. Fernandez, Salvator

   2002 - Forschungsinformationssystem des UKE
9. Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.

   1. Graefen, Markus
   2. Karakiewicz, Pierre I
   3. Cagiannos, Ilias
   4. Hammerer, Peter G
   5. Haese, Alexander
   6. Palisaar, Jüri
   7. Huland, Edith

   2002 - Forschungsinformationssystem des UKE